Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of compound oligosaccharide prescription

A technology of oligosaccharides and prescriptions, which is applied in the field of compound oligosaccharides prescriptions, can solve problems such as difficult treatment and decreased quality of life, and achieve the effects of constant blood sugar levels, reasonable proportions, and laxative effects

Active Publication Date: 2018-08-07
SHANDONG GAOTANG LANSHAN GRP CORP
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, because most of the children have mild symptoms and do not communicate with their parents, they are often ignored by their parents. They do not start to see a doctor until a long time after the onset of the disease, which brings great difficulties to the treatment. Severe constipation affects children's social activities, Psychological development and academic performance have a greater impact, resulting in reduced quality of life

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of compound oligosaccharide prescription
  • A kind of compound oligosaccharide prescription
  • A kind of compound oligosaccharide prescription

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0053] The complex oligosaccharide prescription of the present invention comprises the following components in parts by weight:

[0054] Sucrose 15.37 Stachyose 24.65

[0055] Raffinose 15.92 Fructose 8.18

[0056] Glucose 7.56 Pinitol 0.34

[0057] Mullein sugar 0.14.

[0058] After testing, the sweetness of the compound oligosaccharide formula is 0.82.

[0059] The clinical experiment result of embodiment 1 is as follows:

[0060] Research object and method

[0061] Compound oligosaccharide formula, the appearance is a colorless transparent liquid.

[0062] Clinical Trial 1

[0063] Research objects 60 healthy volunteers aged 2-10 years were randomly selected from the outpatients with constipation in Liaocheng People's Hospital, including 28 males and 32 females, with an average age of 4.3±1.8 years and no gastrointestinal diseases. Medical history, did not take any antibacterial drugs within 2 weeks before sampling.

[0064] Blood routine, urine routine, liver funct...

Embodiment 2

[0133] The complex oligosaccharide prescription of the present invention comprises the following components in parts by weight:

[0134] Sucrose: 20.27 stachyose 24.41

[0135] Raffinose 16.59 Fructose 6.86

[0136] Glucose 8.44 Pinitol 0.42

[0137] Mullein sugar 0.08.

[0138] After testing, the sweetness of the compound oligosaccharide formula is 0.81.

[0139] Embodiment 2 and the following remaining embodiments also adopt the same method as Example 1 to carry out dietary intervention on children, and the results are as follows:

[0140] Table 5 Comparison of subjective symptoms of children before and after dietary intervention in Example 2 (n=60)

[0141]

[0142] P<0.05

Embodiment 3

[0144] Sucrose: 12.26 Stachyose 28.16

[0145] Raffinose 12.19 Fructose 8.33

[0146] Glucose 6.33 Pinitol 0.41

[0147] Mullein sugar 0.08.

[0148] After testing, the sweetness of the compound oligosaccharide formula is 0.85.

[0149] Table 6 Comparison of subjective symptoms in children before and after dietary intervention in Example 3 (n=60)

[0150]

[0151] P<0.05

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of foods and particularly relates to a composite oligosaccharide component. The composite oligosaccharide component disclosed by the invention comprises the following ingredients in parts by weight: 10-30 parts of cane sugar, 20-30 parts of stachyose, 10-20 parts of raffinose, 5-10 parts of fructose, 5-10 parts of glucose, 0.1-0.5 part of pinitol and 0.05-0.15 part of verbascose. Compared with common soybean oligosaccharide, the composite oligosaccharide component disclosed by the invention is high in content of functional sugar, namely the stachyose and the raffinose which have an inhibition effect on blood sugar; so after being eaten, the composite oligosaccharide component has an obvious feces excretion promotion effect; after a diabetic patient eats the composite oligosaccharide component, the blood sugar value is unchanged because the common soybean oligosaccharide has high cane sugar content, while the stachyose and the raffinose have low cane sugar content, so the blood sugar value is unchanged; besides the cane sugar, the stachyose, the raffinose, the fructose and the glucose, the composite oligosaccharide component also contains the pinitol and the verbascose.

Description

technical field [0001] The invention belongs to the field of food, and in particular relates to a compound oligosaccharide formula. Background technique [0002] With the acceleration of the pace of life, the increase of life pressure, and the reduction of people's exercise, constipation, an unspeakable symptom, is accompanied by most white-collar workers. Constipation is one of the more common diseases in daily life. It can be said that it is a digestive disease. Abnormal symptoms of the system, the incidence rate is quite high, basically it can be said that the incidence rate has reached 40%. [0003] Long-term constipation can cause the following hazards: [0004] 1. Cause anorectal disease; 2. Gastrointestinal nerve dysfunction; 3. Form fecal ulcer; 4. Suffer from colon cancer; 5. Induce the onset of cardiovascular and cerebrovascular diseases; Dysmenorrhea; 8. Affect brain function. [0005] Although the above hazards do not occur in all patients, it is enough to sho...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A23L29/30A23L33/25
CPCA23V2002/00A23V2200/30A23V2250/628A23V2250/632A23V2250/606A23V2250/61A23V2200/328A23V2200/3204
Inventor 许兰山许振国赵彬高剑穆洪静郭洪刚宋刚李敬
Owner SHANDONG GAOTANG LANSHAN GRP CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com